Association of Complement Genetics with Outcomes in IgA Nephropathy. [PDF]
Duval A +16 more
europepmc +1 more source
Complement Genetics in IgA Nephropathy: From Biological Plausibility to Tailored Therapy? [PDF]
Frimat M, Nanchen G, Fakhouri F.
europepmc +1 more source
Breaking tolerance in the glomerulus: complement as a driver and therapeutic target in IgA nephropathy. [PDF]
Lu CL, Yang CC, Wu CC, Lu KC.
europepmc +1 more source
Apoptosis Inhibitor of Macrophage and Acute Inflammation in IgA Nephropathy. [PDF]
Kato R +13 more
europepmc +1 more source
Telitacicept for IgA nephropathy: a systematic review and meta-analysis of observational studies. [PDF]
Zheng L +6 more
europepmc +1 more source
IgA nephropathy with rheumatoid arthritis related to adalimumab. [PDF]
Tüfekçi B +3 more
europepmc +1 more source
Research on the safety and efficacy of telitacicept in the treatment of IgA nephropathy in children. [PDF]
Ying L +10 more
europepmc +1 more source
Interpreting the CFH-CFHR Signal in IgA Nephropathy: Caution before Therapeutic Prioritization. [PDF]
Pu H.
europepmc +1 more source
Plasma Proteomics in IgA Nephropathy: From Circulating Biomarkers to Molecular Endotypes. [PDF]
Delrue C +3 more
europepmc +1 more source
Does rs477155 Stratify Glucocorticoid Toxicity in IgA Nephropathy? [PDF]
Yan S, Guo H, Chen Z, Li S.
europepmc +1 more source

